Too Good to be True?

被引：2

作者：

Sebastian, Martin ^{[1
]}

Stratmann, Jan Alexander ^{[1
]}

Eberhardt, Wilfried E. E. ^{[2
]}

机构：

[1] Goethe Univ Frankfurt, Dept Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany

[2] Univ Duisburg, Univ Hosp Essen, West German Canc Ctr, Dept Med Oncol, Essen, Germany

来源：

JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期

关键词：

CELL LUNG-CANCER; THERAPY; ANLOTINIB;

D O I：

10.1016/j.jtho.2021.01.1606

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：507 / 508

页数：2

共 8 条

[1] Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib [J].

Chen, Dongfang ;

Xu, Jianlin ;

Zhao, Yizhuo ;

Chu, Tianqing ;

Zhong, Hua ;

Han, Baohui ;

Zhong, Runbo .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (02) :401-406

[2] Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC [J].

Chu, Tianqing ;

Zhong, Runbo ;

Zhong, Hua ;

Zhang, Bo ;

Zhang, Wei ;

Shi, Chunlei ;

Qian, Jialin ;

Zhang, Yanwei ;

Chang, Qing ;

Zhang, Xueyan ;

Dong, Yu ;

Teng, Jiajun ;

Gao, Zhiqiang ;

Qiang, Huiping ;

Nie, Wei ;

Zhao, Yiming ;

Han, Yuchen ;

Chen, Ya ;

Han, Baohui .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) :643-652

[3] Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma [J].

Finn, Richard S. ;

Qin, Shukui ;

Ikeda, Masafumi ;

Galle, Peter R. ;

Ducreux, Michel ;

Kim, Tae-You ;

Kudo, Masatoshi ;

Breder, Valeriy ;

Merle, Philippe ;

Kaseb, Ahmed O. ;

Li, Daneng ;

Verret, Wendy ;

Xu, Derek-Zhen ;

Hernandez, Sairy ;

Liu, Juan ;

Huang, Chen ;

Mulla, Sohail ;

Wang, Yulei ;

Lim, Ho Yeong ;

Zhu, Andrew X. ;

Cheng, Ann-Lii .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20) :1894-1905

[4] Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302) [J].

Han, Baohui ;

Li, Kai ;

Zhao, Yizhuo ;

Li, Baolan ;

Cheng, Ying ;

Zhou, Jianying ;

Lu, You ;

Shi, Yuankai ;

Wang, Zhehai ;

Jiang, Liyan ;

Luo, Yi ;

Zhang, Yiping ;

Huang, Cheng ;

Li, Qiang ;

Wu, Guoming .

BRITISH JOURNAL OF CANCER, 2018, 118 (05) :654-661

[5] Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa [J].

Khan, Kabir A. ;

Kerbel, Robert S. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (05) :310-324

[6] Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab [J].

Nishino, Mizuki ;

Cryer, Sarah K. ;

Okajima, Yuka ;

Sholl, Lynette M. ;

Hatabu, Hiroto ;

Rabin, Michael S. ;

Jackman, David M. ;

Johnson, Bruce E. .

CANCER IMAGING, 2012, 12 (01) :225-236

[7] Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial [J].

Powles, Thomas ;

Plimack, Elizabeth R. ;

Soulieres, Denis ;

Waddell, Tom ;

Stus, Viktor ;

Gafanov, Rustem ;

Nosov, Dmitry ;

Pouliot, Frederic ;

Melichar, Bohuslav ;

Vynnychenko, Ihor ;

Azevedo, Sergio J. ;

Borchiellini, Delphine ;

McDermott, Raymond S. ;

Bedke, Jens ;

Tamada, Satoshi ;

Yin, Lina ;

Chen, Mei ;

Molife, L. Rhoda ;

Atkins, Michael B. ;

Rini, Brian, I .

LANCET ONCOLOGY, 2020, 21 (12) :1563-1573

[8] Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC [J].

Socinski, M. A. ;

Jotte, R. M. ;

Cappuzzo, F. ;

Orlandi, F. ;

Stroyakovskiy, D. ;

Nogami, N. ;

Rodriguez-Abreu, D. ;

Moro-Sibilot, D. ;

Thomas, C. A. ;

Barlesi, F. ;

Finley, G. ;

Kelsch, C. ;

Lee, A. ;

Coleman, S. ;

Deng, Y. ;

Shen, Y. ;

Kowanetz, M. ;

Lopez-Chavez, A. ;

Sandler, A. ;

Reck, M. ;

Ahualli, A. ;

Jarchum, G. ;

Kaen, D. L. ;

Kahl, S. ;

Kotliar, M. ;

Kowalyszyn, R. D. ;

Lerzo, G. ;

Magri, I ;

Martin, C. ;

Pastor, A. ;

Picon, P. ;

Streich, G. ;

Varela, M. ;

Blinman, P. ;

Boyer, M. ;

Crombie, C. ;

Gauden, S. ;

Gill, S. ;

Hughes, B. ;

John, T. ;

Joshi, A. ;

Kosmider, S. ;

Lewis, C. ;

Millward, M. ;

Nordman, I ;

Nott, L. ;

O'Byrne, K. ;

Parnis, F. ;

Potasz, N. ;

Richardson, G. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (24) :2288-2301

← 1 →